Kuan-pin Su - Academia.edu (original) (raw)

Papers by Kuan-pin Su

Alzheimer's Research & Therapy, Jul 16, 2020

Background: The neuroprotective role of interleukin (IL)-33 is supported by numerous preclinical ... more Background: The neuroprotective role of interleukin (IL)-33 is supported by numerous preclinical studies, but it remains uninvestigated in clinical studies of Alzheimer's disease (AD). We aimed to examine the association between human blood levels of IL-33 and cognitive preservation in amnestic mild cognitive impairment (aMCI) and AD. Methods: A total of 100 participants (26 controls, 35 aMCI patients, and 39 AD patients) completed two Mini-Mental State Examinations (MMSEs) over a 1-year interval. In all 100 participants at the second MMSE, we examined the plasma levels of IL-33, IL-β, IL-1 receptor agonist (IL-1RA), beta amyloid (Aβ), and tau and apolipoprotein E (ApoE) genotyping; we also performed Hopkins Verbal Learning Test, Trail Making Test, forward and backward digit span, and Clinical Dementia Rating. Results: IL-33 expression showed a positive trend among controls (1/26 = 3.8%), aMCI (9/35 = 25.7%), and AD (17/39 = 43.6%) (trend analysis: P < 0.001). Patients expressing IL-33 preserved their cognitive function compared with IL-33 nonexpressing patients (1-year ΔMMSE, 0.16 ± 1.6 vs − 1.5 ± 2.6; P = 0.006). The cognitive preservation was not associated with the lower levels of Aβ, tau, and ApoE ε4, while higher levels of ApoE ε4 and phosphorylated tau were indeed associated with cognitive decline. The aMCI patients with AD conversion during study period had higher proportion of IL-33(−) than non-AD converters (90.9% vs 53.3%, P = 0.04). Conclusions: IL-33 or its associated signaling pathways may represent a new treatment paradigm for aMCI and AD.

Asian Journal of Psychiatry, Oct 1, 2023

Addiction, Aug 4, 2021

Background and aimsNicotine is a highly addictive substance in tobacco products that dysregulates... more Background and aimsNicotine is a highly addictive substance in tobacco products that dysregulates several neurotransmitters in the brain and impairs executive function. Non‐invasive brain stimulation (NIBS) methods such as repetitive transcranial magnetic stimulation (rTMS) and transcranial direct current stimulation (tDCS) are promising treatments for nicotine dependence. We investigated the efficacy and acceptability of NIBS in managing smoking cessation through a systematic review and network meta‐analysis (NMA).MethodsWe conducted a systematic review to identify randomized controlled trials (RCTs) that investigated the efficacy of NIBS for smoking cessation. All pairwise meta‐analyses and NMA procedures were conducted using random‐effects and frequentist models. The co‐primary outcomes were (1) the change in number of cigarettes smoked per day (change in frequency of smoking) in patients with nicotine dependence after NIBS and (2) acceptability (the dropout rate). The effect sizes for co‐primary outcomes of change in frequency of smoking and acceptability were assessed according to standardized mean difference (SMD) and odds ratio, respectively.ResultsTwelve RCTs with 710 participants (mean age: 44.2 years, 31.2% female) were included. Compared with the sham control, 10‐Hz rTMS over the left dorsolateral prefrontal cortex (DLPFC) was associated with the largest changes in smoking frequency [SMD = −1.22, 95% confidence interval (95% CI) = −1.77 to −0.66]. The 2‐mA bifrontal tDCS (SMD = −0.97, 95% CI = −1.32 to −0.62) and 10‐Hz deep rTMS over the bilateral DLPFC with cue provocation (SMD = −0.77, 95% CI = −1.20 to −0.34) were associated with a significantly larger decrease in smoking frequency versus the sham. None of the investigated NIBSs was associated with dropout rates significantly different from those of the sham control groups.ConclusionPrefrontal non‐invasive brain stimulation interventions appear to reduce the number of cigarettes smoked with good acceptability.

Social Science Research Network, 2022

Brain Behavior and Immunity, Oct 1, 2023

Molecular Psychiatry, Jun 16, 2021

Eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA) can exert antidepressant, anti-inflamm... more Eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA) can exert antidepressant, anti-inflammatory and neuroprotective properties, but the exact molecular mechanism underlying their effects is still not fully understood. We conducted both in vitro and clinical investigations to test which EPA or DHA metabolites are involved in these antiinflammatory, neuroprotective and antidepressant effects. In vitro, we used the human hippocampal progenitor cell line HPC0A07/03C, and pre-treated cells with either EPA or DHA, followed by interleukin 1beta (IL1β), IL6 and interferon-alpha (IFN-α). Both EPA and DHA prevented the reduction in neurogenesis and the increase in apoptosis induced by these cytokines; moreover, these effects were mediated by the lipoxygenase (LOX) and cytochrome P450 (CYP450) EPA/DHA metabolites, 5hydroxyeicosapentaenoic acid (HEPE), 4-hydroxydocosahexaenoic acid (HDHA), 18-HEPE, 20-HDHA, 17(18)-epoxyeicosatetraenoic acid (EpETE) and 19(20)-epoxydocosapentaenoic acid (EpDPA), detected here for the first time in human hippocampal neurones using mass spectrometry lipidomics of the supernatant. In fact, like EPA/DHA, co-treatment with these metabolites prevented cytokines-induced reduction in neurogenesis and apoptosis. Moreover, co-treatment with 17(18)-EpETE and 19(20)-EpDPA and the soluble epoxide hydroxylase (sEH) inhibitor, TPPU (which prevents their conversion into dihydroxyeicosatetraenoic acid (DiHETE)/ dihydroxydocosapentaenoic acid (DiHDPA) metabolites) further enhanced their neurogenic and anti-apoptotic effects. Interestingly, these findings were replicated in a sample of n = 22 patients with a DSM-IV Major Depressive Disorder, randomly assigned to treatment with either EPA (3.0 g/day) or DHA (1.4 g/day) for 12 weeks, with exactly the same LOX and CYP450 lipid metabolites increased in the plasma of these patients following treatment with their precursor, EPA or DHA, and some evidence that higher levels of these metabolites were correlated with less severe depressive symptoms. Overall, our study provides the first evidence for the relevance of LOX-and CYP450-derived EPA/DHA bioactive lipid metabolites as neuroprotective molecular targets for human hippocampal neurogenesis and depression, and highlights the importance of sEH inhibitors as potential therapeutic strategy for patients suffering from depressive symptoms.

I-perception, Oct 1, 2012

Gaze is an important social cue and can easily capture attention. Our preference judgment is bias... more Gaze is an important social cue and can easily capture attention. Our preference judgment is biased by others' gaze; that is, we prefer objects gazed by happy or neutral faces and dislike objects gazed by disgust faces. Since patients with depression have a negative bias in emotional perception, we hypothesized that they may have different preference judgment on the gazed objects than healthy controls. Twenty-one patients with major depressive disorder and 21 healthy age-matched controls completed an object categorization task and then rated their preference on those objects. In the categorization task, a schematic face either gazed toward or away from the to-be-categorized object. The results showed that both groups categorized faster for gazed objects than non-gazed objects, suggesting that patients did not have deficits on their attention to gaze cues. Nevertheless, healthy controls preferred gazed objects more than non-gazed objects, while patients did not have significant preference. Our result indic...

SPIRIT Checklist. (DOC 124 kb)

Progress in Lipid Research, 2016

American Journal of Geriatric Psychiatry, Jul 1, 2023

Asian Journal of Psychiatry, Oct 1, 2023

Springer eBooks, 2021

Accumulating evidence suggests that inflammation plays an important role in the pathophysiology a... more Accumulating evidence suggests that inflammation plays an important role in the pathophysiology and therapeutic mechanism across major psychiatric disorders. “Inflammation theory” might not be the full answer for the big picture of mental disorders, but it might explain the high occurrence of somatic symptoms and comorbidity of physical illness in certain subtypes of the heterogeneous groups. Nutritional psychiatric research has been expanding in the past two decades. Epidemiological studies showed that nutritional deficiency has been associated with an increased prevalence of psychiatric disorders, while nutritional supplementation has been shown to reduce or even play a role in the prevention of psychiatric disorders. Moreover, inflammatory regulation has been suggested to be the possible link between nutritional supplementation and psychiatric disorders. Thus, the aim of this chapter is to discuss the role of nutritional supplementations, including omega-3 polyunsaturated fatty acids (n-3 PUFAs) and prebiotics/probiotics, in two commonly seen psychiatric disorders, major depressive disorder (MDD) and attention deficit hyperactivity disorder (ADHD), with inflammatory regulation as the shared mechanism.

Addiction, Aug 4, 2021

Background and aimsNicotine is a highly addictive substance in tobacco products that dysregulates... more Background and aimsNicotine is a highly addictive substance in tobacco products that dysregulates several neurotransmitters in the brain and impairs executive function. Non‐invasive brain stimulation (NIBS) methods such as repetitive transcranial magnetic stimulation (rTMS) and transcranial direct current stimulation (tDCS) are promising treatments for nicotine dependence. We investigated the efficacy and acceptability of NIBS in managing smoking cessation through a systematic review and network meta‐analysis (NMA).MethodsWe conducted a systematic review to identify randomized controlled trials (RCTs) that investigated the efficacy of NIBS for smoking cessation. All pairwise meta‐analyses and NMA procedures were conducted using random‐effects and frequentist models. The co‐primary outcomes were (1) the change in number of cigarettes smoked per day (change in frequency of smoking) in patients with nicotine dependence after NIBS and (2) acceptability (the dropout rate). The effect sizes for co‐primary outcomes of change in frequency of smoking and acceptability were assessed according to standardized mean difference (SMD) and odds ratio, respectively.ResultsTwelve RCTs with 710 participants (mean age: 44.2 years, 31.2% female) were included. Compared with the sham control, 10‐Hz rTMS over the left dorsolateral prefrontal cortex (DLPFC) was associated with the largest changes in smoking frequency [SMD = −1.22, 95% confidence interval (95% CI) = −1.77 to −0.66]. The 2‐mA bifrontal tDCS (SMD = −0.97, 95% CI = −1.32 to −0.62) and 10‐Hz deep rTMS over the bilateral DLPFC with cue provocation (SMD = −0.77, 95% CI = −1.20 to −0.34) were associated with a significantly larger decrease in smoking frequency versus the sham. None of the investigated NIBSs was associated with dropout rates significantly different from those of the sham control groups.ConclusionPrefrontal non‐invasive brain stimulation interventions appear to reduce the number of cigarettes smoked with good acceptability.

Biological Psychiatry, May 1, 2020

Social Science Research Network, 2022

If citing, it is advised that you check and use the publisher's definitive version for pagination... more If citing, it is advised that you check and use the publisher's definitive version for pagination, volume/issue, and date of publication details. And where the final published version is provided on the Research Portal, if citing you are again advised to check the publisher's website for any subsequent corrections.

Brain Behavior and Immunity, Oct 1, 2023

Alzheimer's Research & Therapy, Jul 16, 2020

Background: The neuroprotective role of interleukin (IL)-33 is supported by numerous preclinical ... more Background: The neuroprotective role of interleukin (IL)-33 is supported by numerous preclinical studies, but it remains uninvestigated in clinical studies of Alzheimer's disease (AD). We aimed to examine the association between human blood levels of IL-33 and cognitive preservation in amnestic mild cognitive impairment (aMCI) and AD. Methods: A total of 100 participants (26 controls, 35 aMCI patients, and 39 AD patients) completed two Mini-Mental State Examinations (MMSEs) over a 1-year interval. In all 100 participants at the second MMSE, we examined the plasma levels of IL-33, IL-β, IL-1 receptor agonist (IL-1RA), beta amyloid (Aβ), and tau and apolipoprotein E (ApoE) genotyping; we also performed Hopkins Verbal Learning Test, Trail Making Test, forward and backward digit span, and Clinical Dementia Rating. Results: IL-33 expression showed a positive trend among controls (1/26 = 3.8%), aMCI (9/35 = 25.7%), and AD (17/39 = 43.6%) (trend analysis: P < 0.001). Patients expressing IL-33 preserved their cognitive function compared with IL-33 nonexpressing patients (1-year ΔMMSE, 0.16 ± 1.6 vs − 1.5 ± 2.6; P = 0.006). The cognitive preservation was not associated with the lower levels of Aβ, tau, and ApoE ε4, while higher levels of ApoE ε4 and phosphorylated tau were indeed associated with cognitive decline. The aMCI patients with AD conversion during study period had higher proportion of IL-33(−) than non-AD converters (90.9% vs 53.3%, P = 0.04). Conclusions: IL-33 or its associated signaling pathways may represent a new treatment paradigm for aMCI and AD.

Asian Journal of Psychiatry, Oct 1, 2023

Addiction, Aug 4, 2021

Background and aimsNicotine is a highly addictive substance in tobacco products that dysregulates... more Background and aimsNicotine is a highly addictive substance in tobacco products that dysregulates several neurotransmitters in the brain and impairs executive function. Non‐invasive brain stimulation (NIBS) methods such as repetitive transcranial magnetic stimulation (rTMS) and transcranial direct current stimulation (tDCS) are promising treatments for nicotine dependence. We investigated the efficacy and acceptability of NIBS in managing smoking cessation through a systematic review and network meta‐analysis (NMA).MethodsWe conducted a systematic review to identify randomized controlled trials (RCTs) that investigated the efficacy of NIBS for smoking cessation. All pairwise meta‐analyses and NMA procedures were conducted using random‐effects and frequentist models. The co‐primary outcomes were (1) the change in number of cigarettes smoked per day (change in frequency of smoking) in patients with nicotine dependence after NIBS and (2) acceptability (the dropout rate). The effect sizes for co‐primary outcomes of change in frequency of smoking and acceptability were assessed according to standardized mean difference (SMD) and odds ratio, respectively.ResultsTwelve RCTs with 710 participants (mean age: 44.2 years, 31.2% female) were included. Compared with the sham control, 10‐Hz rTMS over the left dorsolateral prefrontal cortex (DLPFC) was associated with the largest changes in smoking frequency [SMD = −1.22, 95% confidence interval (95% CI) = −1.77 to −0.66]. The 2‐mA bifrontal tDCS (SMD = −0.97, 95% CI = −1.32 to −0.62) and 10‐Hz deep rTMS over the bilateral DLPFC with cue provocation (SMD = −0.77, 95% CI = −1.20 to −0.34) were associated with a significantly larger decrease in smoking frequency versus the sham. None of the investigated NIBSs was associated with dropout rates significantly different from those of the sham control groups.ConclusionPrefrontal non‐invasive brain stimulation interventions appear to reduce the number of cigarettes smoked with good acceptability.

Social Science Research Network, 2022

Brain Behavior and Immunity, Oct 1, 2023

Molecular Psychiatry, Jun 16, 2021

Eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA) can exert antidepressant, anti-inflamm... more Eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA) can exert antidepressant, anti-inflammatory and neuroprotective properties, but the exact molecular mechanism underlying their effects is still not fully understood. We conducted both in vitro and clinical investigations to test which EPA or DHA metabolites are involved in these antiinflammatory, neuroprotective and antidepressant effects. In vitro, we used the human hippocampal progenitor cell line HPC0A07/03C, and pre-treated cells with either EPA or DHA, followed by interleukin 1beta (IL1β), IL6 and interferon-alpha (IFN-α). Both EPA and DHA prevented the reduction in neurogenesis and the increase in apoptosis induced by these cytokines; moreover, these effects were mediated by the lipoxygenase (LOX) and cytochrome P450 (CYP450) EPA/DHA metabolites, 5hydroxyeicosapentaenoic acid (HEPE), 4-hydroxydocosahexaenoic acid (HDHA), 18-HEPE, 20-HDHA, 17(18)-epoxyeicosatetraenoic acid (EpETE) and 19(20)-epoxydocosapentaenoic acid (EpDPA), detected here for the first time in human hippocampal neurones using mass spectrometry lipidomics of the supernatant. In fact, like EPA/DHA, co-treatment with these metabolites prevented cytokines-induced reduction in neurogenesis and apoptosis. Moreover, co-treatment with 17(18)-EpETE and 19(20)-EpDPA and the soluble epoxide hydroxylase (sEH) inhibitor, TPPU (which prevents their conversion into dihydroxyeicosatetraenoic acid (DiHETE)/ dihydroxydocosapentaenoic acid (DiHDPA) metabolites) further enhanced their neurogenic and anti-apoptotic effects. Interestingly, these findings were replicated in a sample of n = 22 patients with a DSM-IV Major Depressive Disorder, randomly assigned to treatment with either EPA (3.0 g/day) or DHA (1.4 g/day) for 12 weeks, with exactly the same LOX and CYP450 lipid metabolites increased in the plasma of these patients following treatment with their precursor, EPA or DHA, and some evidence that higher levels of these metabolites were correlated with less severe depressive symptoms. Overall, our study provides the first evidence for the relevance of LOX-and CYP450-derived EPA/DHA bioactive lipid metabolites as neuroprotective molecular targets for human hippocampal neurogenesis and depression, and highlights the importance of sEH inhibitors as potential therapeutic strategy for patients suffering from depressive symptoms.

I-perception, Oct 1, 2012

Gaze is an important social cue and can easily capture attention. Our preference judgment is bias... more Gaze is an important social cue and can easily capture attention. Our preference judgment is biased by others' gaze; that is, we prefer objects gazed by happy or neutral faces and dislike objects gazed by disgust faces. Since patients with depression have a negative bias in emotional perception, we hypothesized that they may have different preference judgment on the gazed objects than healthy controls. Twenty-one patients with major depressive disorder and 21 healthy age-matched controls completed an object categorization task and then rated their preference on those objects. In the categorization task, a schematic face either gazed toward or away from the to-be-categorized object. The results showed that both groups categorized faster for gazed objects than non-gazed objects, suggesting that patients did not have deficits on their attention to gaze cues. Nevertheless, healthy controls preferred gazed objects more than non-gazed objects, while patients did not have significant preference. Our result indic...

SPIRIT Checklist. (DOC 124 kb)

Progress in Lipid Research, 2016

American Journal of Geriatric Psychiatry, Jul 1, 2023

Asian Journal of Psychiatry, Oct 1, 2023

Springer eBooks, 2021

Accumulating evidence suggests that inflammation plays an important role in the pathophysiology a... more Accumulating evidence suggests that inflammation plays an important role in the pathophysiology and therapeutic mechanism across major psychiatric disorders. “Inflammation theory” might not be the full answer for the big picture of mental disorders, but it might explain the high occurrence of somatic symptoms and comorbidity of physical illness in certain subtypes of the heterogeneous groups. Nutritional psychiatric research has been expanding in the past two decades. Epidemiological studies showed that nutritional deficiency has been associated with an increased prevalence of psychiatric disorders, while nutritional supplementation has been shown to reduce or even play a role in the prevention of psychiatric disorders. Moreover, inflammatory regulation has been suggested to be the possible link between nutritional supplementation and psychiatric disorders. Thus, the aim of this chapter is to discuss the role of nutritional supplementations, including omega-3 polyunsaturated fatty acids (n-3 PUFAs) and prebiotics/probiotics, in two commonly seen psychiatric disorders, major depressive disorder (MDD) and attention deficit hyperactivity disorder (ADHD), with inflammatory regulation as the shared mechanism.

Addiction, Aug 4, 2021

Background and aimsNicotine is a highly addictive substance in tobacco products that dysregulates... more Background and aimsNicotine is a highly addictive substance in tobacco products that dysregulates several neurotransmitters in the brain and impairs executive function. Non‐invasive brain stimulation (NIBS) methods such as repetitive transcranial magnetic stimulation (rTMS) and transcranial direct current stimulation (tDCS) are promising treatments for nicotine dependence. We investigated the efficacy and acceptability of NIBS in managing smoking cessation through a systematic review and network meta‐analysis (NMA).MethodsWe conducted a systematic review to identify randomized controlled trials (RCTs) that investigated the efficacy of NIBS for smoking cessation. All pairwise meta‐analyses and NMA procedures were conducted using random‐effects and frequentist models. The co‐primary outcomes were (1) the change in number of cigarettes smoked per day (change in frequency of smoking) in patients with nicotine dependence after NIBS and (2) acceptability (the dropout rate). The effect sizes for co‐primary outcomes of change in frequency of smoking and acceptability were assessed according to standardized mean difference (SMD) and odds ratio, respectively.ResultsTwelve RCTs with 710 participants (mean age: 44.2 years, 31.2% female) were included. Compared with the sham control, 10‐Hz rTMS over the left dorsolateral prefrontal cortex (DLPFC) was associated with the largest changes in smoking frequency [SMD = −1.22, 95% confidence interval (95% CI) = −1.77 to −0.66]. The 2‐mA bifrontal tDCS (SMD = −0.97, 95% CI = −1.32 to −0.62) and 10‐Hz deep rTMS over the bilateral DLPFC with cue provocation (SMD = −0.77, 95% CI = −1.20 to −0.34) were associated with a significantly larger decrease in smoking frequency versus the sham. None of the investigated NIBSs was associated with dropout rates significantly different from those of the sham control groups.ConclusionPrefrontal non‐invasive brain stimulation interventions appear to reduce the number of cigarettes smoked with good acceptability.

Biological Psychiatry, May 1, 2020

Social Science Research Network, 2022

If citing, it is advised that you check and use the publisher's definitive version for pagination... more If citing, it is advised that you check and use the publisher's definitive version for pagination, volume/issue, and date of publication details. And where the final published version is provided on the Research Portal, if citing you are again advised to check the publisher's website for any subsequent corrections.

Brain Behavior and Immunity, Oct 1, 2023